Overview

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Status:
NOT_YET_RECRUITING

Trial end date:
2028-12-30

Target enrollment:

Participant gender:

Summary

This is clinical trial evaluating the safety and efficacy of radiotherapy combined with immunotherapy and chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC) and liver metastases.

Phase:

PHASE2

Details

Lead Sponsor:

Sichuan University

Treatments:

130-nm albumin-bound paclitaxel
Drug Therapy
Etoposide
Immunotherapy
Irinotecan
PM 01183
Radiation
Radiosurgery